ClinicalTrials.Veeva

Menu

HCV Microfluidic Diagnostics

U

University of Hull

Status

Completed

Conditions

Hepatitis C

Study type

Observational

Funder types

Other

Identifiers

NCT06047275
RS193 - 323660

Details and patient eligibility

About

Hepatitis C diagnostic devices have been developed at the University of Hull to detect and quantify the Hepatitis C virus in patients' plasma and serum samples. This study aims to test the new point-of-care devices that are designed to be low cost and user-friendly.

Excess, stored, HCV patients' plasma, serum and blood samples will be supplied by the Virology laboratory (Hull University Teaching Hospital's Trust; HUTH). These samples were taken and analysed as part of patients' clinical monitoring, and are stored prior to disposal in the Virology laboratory. The proposed study will use the samples in a fully anonymised manner.

Enrollment

38 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Blood sample taken

Exclusion criteria

  • None

Trial design

38 participants in 2 patient groups

Test
Description:
Hep C positive
Control
Description:
Hep C negative

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems